Universal Beteiligungs und Servicegesellschaft mbH Sells 26,543 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Universal Beteiligungs und Servicegesellschaft mbH lessened its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 14.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 162,649 shares of the medical device company's stock after selling 26,543 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.08% of Cooper Companies worth $13,719,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Wealth Alliance LLC boosted its holdings in shares of Cooper Companies by 5.5% during the first quarter. Wealth Alliance LLC now owns 4,059 shares of the medical device company's stock valued at $342,000 after acquiring an additional 210 shares during the period. Teachers Retirement System of The State of Kentucky boosted its holdings in shares of Cooper Companies by 4.4% during the first quarter. Teachers Retirement System of The State of Kentucky now owns 15,369 shares of the medical device company's stock valued at $1,296,000 after acquiring an additional 641 shares during the period. Buckhead Capital Management LLC boosted its holdings in shares of Cooper Companies by 9.5% during the first quarter. Buckhead Capital Management LLC now owns 52,711 shares of the medical device company's stock valued at $4,446,000 after acquiring an additional 4,591 shares during the period. Diversify Advisory Services LLC boosted its holdings in shares of Cooper Companies by 30.7% during the first quarter. Diversify Advisory Services LLC now owns 5,432 shares of the medical device company's stock valued at $447,000 after acquiring an additional 1,276 shares during the period. Finally, Forum Financial Management LP boosted its holdings in shares of Cooper Companies by 41.5% during the first quarter. Forum Financial Management LP now owns 5,433 shares of the medical device company's stock valued at $458,000 after acquiring an additional 1,593 shares during the period. Institutional investors and hedge funds own 24.39% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on COO. BNP Paribas upgraded shares of Cooper Companies from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, July 22nd. UBS Group upgraded shares of Cooper Companies to a "buy" rating in a research note on Tuesday, June 17th. Mizuho cut their price objective on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 16th. BNP Paribas Exane upgraded shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price target on the stock in a research report on Tuesday, July 22nd. Finally, Robert W. Baird dropped their price target on shares of Cooper Companies from $107.00 to $97.00 and set an "outperform" rating on the stock in a research report on Friday, May 30th. Three investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $96.73.

Cooper Companies Stock Performance

Shares of COO stock traded down $0.87 during trading hours on Monday, reaching $73.72. 164,820 shares of the company's stock were exchanged, compared to its average volume of 2,221,853. The Cooper Companies, Inc. has a fifty-two week low of $65.00 and a fifty-two week high of $112.38. The stock has a market capitalization of $14.74 billion, a P/E ratio of 35.84, a P/E/G ratio of 1.82 and a beta of 0.99. The business has a fifty day moving average price of $73.14 and a 200-day moving average price of $81.25. The company has a quick ratio of 1.23, a current ratio of 2.10 and a debt-to-equity ratio of 0.30.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.93 by $0.03. The firm had revenue of $1 billion during the quarter, compared to analyst estimates of $995.12 million. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The business's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period in the prior year, the company posted $0.85 earnings per share. Analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.